Diese Präsentation wurde erfolgreich gemeldet.
Die SlideShare-Präsentation wird heruntergeladen. ×

2. IMMUNIZABLE DISEASES I - DPT & Pertusis.ppt

Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Nächste SlideShare
Mumps
Mumps
Wird geladen in …3
×

Hier ansehen

1 von 25 Anzeige

Weitere Verwandte Inhalte

Aktuellste (20)

Anzeige

2. IMMUNIZABLE DISEASES I - DPT & Pertusis.ppt

  1. 1. THE IMMUNIZABLE DISEASES I Whooping Cough, Diphtheria ANN MURIITHI-MUGO Ann Muriithi-Mugo 1
  2. 2. OBJECTIVES 1. To know the disease entities that constitute the immunizable diseases. 2. To understand the clinical presentation, diagnosis, management and prevention of each of the immunizable diseases. Ann Muriithi-Mugo 2
  3. 3. Immunizable diseases The six childhood immunizable diseases targeted by KEPI are: 1. Tuberculosis (TB) 2. Poliomyelitis (Polio) 3. Diphtheria 4. Pertussis (Whooping cough) 5. Tetanus 6. Measles Ann Muriithi-Mugo 3
  4. 4. Reasons these are target diseases: 1. The vaccines for their immunization are available, cheap and effective and give long term immunity. 2. These diseases are among the highest cause of mortality and morbidity among the under-five children. 3. The diseases are immunizable and it is cheaper to immunise children than to treat them. 4. The diseases are highly contagious among children hence leading to epidemics. But if many are vaccinated a community may develop herd immunity thus reducing the spread of diseases. Ann Muriithi-Mugo 4
  5. 5. Target groups for KEPI 1. Infants (under one year) 2. Children 1 - 9 years 3. Women of child bearing age (19-49) 4. Pregnant mothers NB: It is now routine practice to immunise against Hepatitis B and haemophilus Influenzae type B in Kenya. Ann Muriithi-Mugo 5
  6. 6. WHOOPING COUGH Whooping cough is which is also known as pertussis, is an acute respiratory tract infection caused by a bacterium called Bordetella pertussis. -Mode of transmission is by droplet inhalation. -The incubation period is 7-10 days. Ann Muriithi-Mugo 6
  7. 7. Clinical presentation Ann Muriithi-Mugo 7
  8. 8. Clinical presentation cont.. • The signs and symptoms of whooping cough vary with the age of the child. • If a child is under 6 months of age, he/she will present with: -Fever -A cough that does not end with a whoop and lasts more than three weeks. • If a child is six months of age or more, he/she will present with: -Fever -Sneezing, watering of eyes and irritation of the throat. Ann Muriithi-Mugo 8
  9. 9. Clinical presentation cont.. -Paroxysms of coughing followed by a whooping sound at the end of long coughing spell. The spell may end in vomiting and gasp for breath. -Talking, coughing or crying can precipitate the paroxysms of cough. -The under side of the tongue may become sore and ulcerate. -Attacks are more frequent at night and the cough can last several weeks. Ann Muriithi-Mugo 9
  10. 10. DIAGNOSIS •Diagnosis is done clinically in most cases. •Culture of the organism from pharyngeal secretions. •PCR on the secretions. Ann Muriithi-Mugo 10
  11. 11. COMPLICATIONS • Pneumonia • Convulsions • Encephalopathy with brain damage • Malnutrition due to vomiting and loss of appetite Ann Muriithi-Mugo 11
  12. 12. MANAGEMENT 1. Supportive: -Encourage the mother to give nutritious food to prevent malnutrition. -Encourage breastfeeding or the drinking of plenty of oral fluids immediately after a coughing attack to prevent dehydration. -Avoid giving sedatives or cough suppressants because they may make the illness worse. Ann Muriithi-Mugo 12
  13. 13. Management cont.. 2. Definitive treatment: -Antibiotics: Macrolides- Erythromycin, clarithromycin or Azithromycin or trimethoprim and sulphamethoxazole. -IV fluids -Antipyretics NB: Refer the child to hospital immediately for further management and anticipate complications. Ann Muriithi-Mugo 13
  14. 14. PREVENTION • Whooping cough is vaccine preventable using the Pentavalent vaccine. • Isolation of those suffering from whooping cough. • Sending all suspected cases of whooping cough for treatment in the hospital. Ann Muriithi-Mugo 14
  15. 15. DIPHTHERIA • Diphtheria is an acute infectious disease of the throat and tonsils, caused by bacteria known as Corynebacterium Diphtheriae, a facultative anaerobic Gram-positive bacterium. • These bacteria produce typical lesions on the mucous membrane of the upper respiratory tract. • A milder form of diphtheria can be restricted to the skin. • Toxins released from the lesions are responsible for severe general symptoms and can cause damage to the heart and peripheral nerves. • The incubation period is 2 - 9 days. Ann Muriithi-Mugo 15
  16. 16. Mode of Transmission: –Droplet inhalation. –Ingestion of contaminated milk. –Skin to skin contact. Ann Muriithi-Mugo 16
  17. 17. Clinical presentation Ann Muriithi-Mugo 17
  18. 18. Bull neck Ann Muriithi-Mugo 18
  19. 19. Skin lesion Ann Muriithi-Mugo 19
  20. 20. Clinical presentation cont… •The child has fever and is acutely sick and toxic. •The neck is enormously swollen –Bullneck. •Sore throat with hoarseness and difficulty in swallowing. •Grey membrane at the back of the throat that spreads past the tonsils. The membrane looks like small piece of a dirty cloth stuck to the child's throat and may suffocate the child to death. Ann Muriithi-Mugo 20
  21. 21. Complications • Myocarditis - the local lesion’s toxins attack the heart muscle, causing signs of cardiac failure. • Respiratory paralysis. • Peripheral neuropathy, causing paralysis of the limbs. Ann Muriithi-Mugo 21
  22. 22. Diagnosis • Through the isolation of the bacteria from pharyngeal specimen. • Through clinical criteria: -URTI with sore throat, -Low grade fever, -Adherent pseudomembrane on the throat, pharynx and, or nasal cavity. Ann Muriithi-Mugo 22
  23. 23. Management Supportive treatment: - Intubation or a tracheotomy with mechanical ventilation for those with features of upper airway obstruction - Arrhythmias can occur early in the course of the illness or weeks later, and can lead to heart failure. Thus monitor and treat. - Diphtheria antitoxin given early in the course of the illness to prevent paralysis in the eye, neck, throat, or respiratory muscles. NB: antitoxin does not neutralize toxin that is already bound to tissues, delaying its administration is associated with an increase in mortality risk. Ann Muriithi-Mugo 23
  24. 24. Management cont… Definitive Treatment: • Empirical treatment should be started in a patient in whom suspicion of diphtheria is high. Drugs recommended are: -Metronidazole -Erythromycin (orally or by injection) for 14 days (40 mg/kg) -Procaine penicillin G given intramuscular for 14 days • Patients with allergies to penicillin G or erythromycin can use Rifampicin or Clindamycin. Ann Muriithi-Mugo 24
  25. 25. Prevention Diphtheria can be prevented by Immunisation using the Pentavalent vaccine. Ann Muriithi-Mugo 25

×